)
Visual
earnings real time
Jazz Pharmaceuticals (JAZZ) investor relations material
Jazz Pharmaceuticals Citi Annual Global Healthcare Conference 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Citi Annual Global Healthcare Conference 2025 summary2 Dec, 2025
Financial performance and guidance
Achieved record Q3 revenues of $1.13 billion, up 7%, driven by strong growth in Epidiolex and Xywav.
Narrowed full-year revenue guidance range and raised ANI and EPS guidance due to strong momentum and disciplined expense management.
Recognized a $206 million deferred tax asset from the Chimerix acquisition, enhancing future tax efficiency.
Ended the quarter with $2 billion in cash and investments, generating $1 billion in cash flow over nine months.
Approved Zepzelca for first-line maintenance, expanding oncology portfolio.
Business development and capital allocation
Chimerix acquisition provided a long-lived asset with strong patent protection and significant tax benefits.
Focused on assets with high unmet need, durable responses, and strategic fit, especially in rare diseases and oncology.
SAN2355 licensing aims to build on epilepsy leadership, leveraging Epidiolex's backbone status and exclusivity into the late 2030s.
Open to a range of deal structures, including licensing and risk-sharing, with a balanced BD climate and rational valuations.
Investors favor continued external innovation through BD and M&A, while maintaining internal growth opportunities.
Commercial portfolio performance
Xywav's growth led by idiopathic hypersomnia (IH), with majority of new patients from IH and continued strength in narcolepsy despite competition.
Xywav's low-sodium profile offers cardiovascular benefits, supporting its adoption in both IH and narcolepsy.
Anticipates generic Xyrem entry in 2026, with Xywav's impact dependent on generic competition and payer actions.
Epidiolex on track for blockbuster status, driven by patient identification tools, nurse navigator programs, and expansion into adult populations.
Rylaze highly penetrated in pediatrics, with growth focus shifting to adolescent and young adult settings.
Modeyso growth strategy before ACTION trial OS data
Xywav strategy for 2026 generic Xyrem entry
Zanidatamab: How to supplant Herceptin in 1L GEA?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Jazz Pharmaceuticals earnings date
Status Update9 Jan, 2026
Next Jazz Pharmaceuticals earnings date
Status Update9 Jan, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Jazz Pharmaceuticals plc is a biopharmaceutical company focused on developing and commercializing treatments for neurological disorders, sleep medicine, and oncology. The company’s portfolio includes products designed to address rare and complex conditions, particularly in the areas of sleep disorders, epilepsy, and cancer. Jazz Pharmaceuticals engages in research, development, and global distribution of its therapies, working to advance treatment options for patients with unmet medical needs. The company is headquartered in Dublin, Ireland, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage